You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Moodys
Mallinckrodt
Dow
Express Scripts

Last Updated: May 29, 2020

DrugPatentWatch Database Preview

Corepharma Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for COREPHARMA, and what generic and branded alternatives to COREPHARMA drugs are available?

COREPHARMA has nine approved drugs.

There is one tentative approval on COREPHARMA drugs.

Summary for Corepharma
US Patents:0
Tradenames:9
Ingredients:9
NDAs:9
Patent Litigation for Corepharma: See patent lawsuits for Corepharma

Drugs and US Patents for Corepharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corepharma LISINOPRIL lisinopril TABLET;ORAL 076102-006 Sep 30, 2002 AB RX No No   Start Trial   Start Trial
Corepharma CAPTOPRIL captopril TABLET;ORAL 074737-004 Oct 28, 1998 DISCN No No   Start Trial   Start Trial
Corepharma BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 077128-004 Mar 8, 2006 AB RX No No   Start Trial   Start Trial
Corepharma LISINOPRIL lisinopril TABLET;ORAL 076102-002 Sep 30, 2002 AB RX No No   Start Trial   Start Trial
Corepharma CAPTOPRIL captopril TABLET;ORAL 074737-003 Oct 28, 1998 DISCN No No   Start Trial   Start Trial
Corepharma LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076674-001 Oct 5, 2004 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Colorcon
Boehringer Ingelheim
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.